Pluri
Business Services · 1-10 Employees
View Company Info for Free
Overview
Website
www.pluricorp.comRevenue
<$5 MillionIndustry
About Pluri
Pluri Org Chart
Is Pluri your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Pluri had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Pluri
Product Launch: Get notified when Pluri launches new products
Check if Pluri has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Pluri has new funding data
Pluri, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Pluri is spiking on competitors!
Earning: See what the market has to say on Pluri recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Pluri
Find 3 more new buyers
Compare Similar Companies to Pluri
Compare insights from companies similar to Pluri, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pluri is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Pluri is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Pluri.
Pluri Tech Stack
A closer look at the technologies used by Pluri
Pluri News & Media
NIH nixes financing for Pluri's radiation exposure cell therapy - Fierce Biotech
The U.S. government has pulled the rug out from under Pluri Biotech’s PLX-R18 cell therapy. | The U.S. government has pulled the rug out from under Pluri Biotech’s PLX-R18 cell therapy. Having put up funding to help bring the candidate to market, the government terminated the contract in a move that Pluri believes “may reflect broader federal budgetary and administrative adjustments."Pluri Secures $6.5 Million Investment and Acquires Majority Stake in Cell-Based Cacao ...
Biotechnology firm Pluri Inc., a company specializing in cell-based technology, has announced a $6.5 million private investment led by global investorPluri Announces Appointment of Entrepreneur Lorne Abony to Board of Directors
Abony: “Pluri’s cell expansion technology has extraordinary potential across a range of industries.” Mr. Lorne Abony Mr. Lorne Abony HAIFA, Israel, July 13, 2023 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote wellbeing and sustainability, today announced the appointment of Lorne Abony to the Company’s Board of Directors, effective as of July 11, 2023. Abony is a successful entrepre
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pluri
Pluri Inc. specializes in custom algorithm engineering for scientific laboratories and businesses, providing innovative AI solutions inspired by neuroscience. Their offerings include StremeCoder, a customizable platform for algorithm development, and Plurilabs AI, which enhances search capabilities across databases. They cater to a diverse clientel... Read More